Literature DB >> 27431677

HIV and decreased risk of multiple sclerosis: role of low CD4+ lymphocyte count and male prevalence.

Tatiana Koudriavtseva1,2, Domenico Plantone3, Chiara Mandoj4, Diana Giannarelli5, Alessandra Latini6, Manuela Colafigli6, Elisabetta Trento7, Paola Cordiali-Fei7, Fulvia Pimpinelli7.   

Abstract

In this retrospective case-control study, we compared the number of circulating lymphocyte subsets among 31 healthy controls, 18 naïve and 40 antiretroviral-treated HIV patients, 28 untreated and 18 treated relapsing-remitting multiple sclerosis (MS) patients. Lymphocyte subsets were no different between untreated MS patients and controls. Untreated and treated MS had a lower CD8+ count and a higher CD4+ number compared to untreated and treated HIV patients except similar CD4+ number between treated MS and HIV patients. CD4/CD8 ratio was lower in female HIV non-responders and in relapsing MS women compared, respectively, to female HIV responders and remitting MS women, and there were no differences in men.

Entities:  

Keywords:  CD4+ count; HIV positive dermatological patients; Multiple Sclerosis; circulating lymphocytes; gender

Mesh:

Substances:

Year:  2016        PMID: 27431677     DOI: 10.1007/s13365-016-0471-2

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  19 in total

Review 1.  Natural killer cells in human autoimmune diseases.

Authors:  Nicolas Schleinitz; Frédéric Vély; Jean-Robert Harlé; Eric Vivier
Journal:  Immunology       Date:  2010-10-13       Impact factor: 7.397

2.  Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection.

Authors:  Galit Alter; Nickolas Teigen; Benjamin T Davis; Marylyn M Addo; Todd J Suscovich; Michael T Waring; Hendrik Streeck; Mary N Johnston; Kyle D Staller; M Tauheed Zaman; Xu G Yu; Mathias Lichterfeld; Nesli Basgoz; Eric S Rosenberg; Marcus Altfeld
Journal:  Blood       Date:  2005-07-07       Impact factor: 22.113

3.  Lymphocyte subsets' reference ranges in an age- and gender-balanced population of 100 healthy adults--a monocentric German study.

Authors:  Kathleen Jentsch-Ullrich; Michael Koenigsmann; Martin Mohren; Astrid Franke
Journal:  Clin Immunol       Date:  2005-08       Impact factor: 3.969

Review 4.  Role of natural killer cells in the pathogenesis and progression of multiple sclerosis.

Authors:  Barbara Morandi; Placido Bramanti; Irene Bonaccorsi; Erika Montalto; Daniela Oliveri; Gaetana Pezzino; Michele Navarra; Guido Ferlazzo
Journal:  Pharmacol Res       Date:  2007-11-17       Impact factor: 7.658

5.  Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy.

Authors:  Aurélie Vendrely; Boris Bienvenu; Jacques Gasnault; Jean Baptiste Thiebault; Dominique Salmon; Françoise Gray
Journal:  Acta Neuropathol       Date:  2005-03-01       Impact factor: 17.088

Review 6.  CNS demyelinating disorder with mixed features of neuromyelitis optica and multiple sclerosis in HIV-1 infection. Case report and literature review.

Authors:  Silvia R Delgado; Janice Maldonado; Kottil W Rammohan
Journal:  J Neurovirol       Date:  2014-07-01       Impact factor: 2.643

Review 7.  Human immunodeficiency virus type 1 long-term non-progressors: the viral, genetic and immunological basis for disease non-progression.

Authors:  Kate Poropatich; David J Sullivan
Journal:  J Gen Virol       Date:  2010-11-24       Impact factor: 3.891

8.  Multiple sclerosis and HIV-1 infection: case report of a HIV controller.

Authors:  Jerome H Chin
Journal:  J Neurovirol       Date:  2015-03-24       Impact factor: 2.643

9.  Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals.

Authors:  Domenico Mavilio; Gabriella Lombardo; Janet Benjamin; Diana Kim; Dean Follman; Emanuela Marcenaro; M Angeline O'Shea; Audrey Kinter; Colin Kovacs; Alessandro Moretta; Anthony S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-07       Impact factor: 11.205

10.  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors:  Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

View more
  4 in total

Review 1.  Multiple Sclerosis and Subsequent Human Immunodeficiency Virus Infection: A Case with the Rare Comorbidity, Focus on Novel Treatment Issues and Review of the Literature.

Authors:  Charalampos Skarlis; Maria Gontika; Serafeim Katsavos; Giorgios Velonakis; Panagiotis Toulas; Maria Anagnostouli
Journal:  In Vivo       Date:  2017 Sep-Oct       Impact factor: 2.155

2.  HIV infection and multiple sclerosis: a case with unexpected "no evidence of disease activity" status.

Authors:  Fernando Labella; Fernando Acebrón; María Del Carmen Blanco-Valero; Alba Rodrígez-Martín; Ángela Monterde Ortega; Eduardo Agüera Morales
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

Review 3.  Human immunodeficiency virus and multiple sclerosis: a review of the literature.

Authors:  Maria-Ioanna Stefanou; Markus Krumbholz; Ulf Ziemann; Markus C Kowarik
Journal:  Neurol Res Pract       Date:  2019-08-20

4.  HIV-1 Env Does Not Enable the Development of Protective Broadly Neutralizing Antibodies in an Experimental Autoimmune Encephalomyelitis Mouse Model.

Authors:  Gabriel Siracusano; Annamaria Finardi; Claudia Pastori; Vittorio Martinelli; Roberto Furlan; Lucia Lopalco
Journal:  Front Immunol       Date:  2021-11-02       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.